RxSource is the Solution to your Drug Shortage Problem
India’s drug makers rely on China for almost 70% of the active ingredients in their medicines. The Government of India has enforced a restriction of exports on selected APIs, which will have an impact on the EU that rely on generics from Indian manufacturers. This restriction is undated and in force until further notice. Exports represent almost 26% of the European formulations in the generic space, and 24% for the US. Meanwhile, the EMA and FDA work to determine how restrictions will affect supplies.
How we can help
We work closely with generic manufacturers in Canada and can support your immediate patient needs. Send us an email to at email@example.com and we will help you through the restricted list we have and find solutions for patients in need.